Genentech Phase I Trial MPD3280A

My local Cleveland Clinic onc and Johns Hopkins onc have recommended a Phase I trial.  The results are proving to be very positive and even though it is Phase I they are excited about the results discussed at a recent ASCO convention. This trial is being studied at numerous locations across the country and abroad.

Is anyone participating in this trial?  The identifier is NCT01375842.